The FUNCTIONAL PROTEOMICS DRUG DISCOVERY CENTER (FPDDC) was established in 2022 as a member of the Chemical Biology Consortium (CBC), part of the NCI Experimental Therapeutics (NExT) Program. Anchored by the Proteome Exploration Laboratory (PEL) in Caltech's Beckman Institute, FPDDC collaborates with other labs and research groups on the Caltech campus (see Facilities) to support small molecule drug discovery for the project teams in the NExT program.